Laboratorios Farmaceuticos Rovi, S.A. (FRA:41L)

FRA:41L Statistics

Total Valuation

FRA:41L has a market cap or net worth of EUR 3.04 billion. The enterprise value is 3.13 billion.

Market Cap	3.04B
Enterprise Value	3.13B

Important Dates

The next estimated earnings date is Monday, February 23, 2026.

Earnings Date	Feb 23, 2026
Ex-Dividend Date	Jul 14, 2025

Share Statistics

Current Share Class	51.15M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	14.20%
Float	16.65M

Valuation Ratios

The trailing PE ratio is 25.10 and the forward PE ratio is 20.51.

PE Ratio	25.10
Forward PE	20.51
PS Ratio	4.20
PB Ratio	4.81
P/TBV Ratio	5.19
P/FCF Ratio	27.39
P/OCF Ratio	17.42
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.46, with an EV/FCF ratio of 28.16.

EV / Earnings	25.80
EV / Sales	4.32
EV / EBITDA	17.46
EV / EBIT	20.77
EV / FCF	28.16

Financial Position

The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.20.

Current Ratio	3.02
Quick Ratio	1.30
Debt / Equity	0.20
Debt / EBITDA	0.69
Debt / FCF	1.11
Interest Coverage	53.49

Financial Efficiency

Return on equity (ROE) is 20.34% and return on invested capital (ROIC) is 13.05%.

Return on Equity (ROE)	20.34%
Return on Assets (ROA)	10.46%
Return on Invested Capital (ROIC)	13.05%
Return on Capital Employed (ROCE)	20.44%
Revenue Per Employee	329,631
Profits Per Employee	55,145
Employee Count	2,197
Asset Turnover	0.80
Inventory Turnover	0.82

Taxes

In the past 12 months, FRA:41L has paid 36.41 million in taxes.

Income Tax	36.41M
Effective Tax Rate	23.12%

Stock Price Statistics

The stock price has decreased by -6.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.71%
50-Day Moving Average	59.48
200-Day Moving Average	55.43
Relative Strength Index (RSI)	47.68
Average Volume (20 Days)	38

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:41L had revenue of EUR 724.20 million and earned 121.15 million in profits. Earnings per share was 2.37.

Revenue	724.20M
Gross Profit	451.91M
Operating Income	150.58M
Pretax Income	157.52M
Net Income	121.15M
EBITDA	173.12M
EBIT	150.58M
Earnings Per Share (EPS)	2.37

Balance Sheet

The company has 49.25 million in cash and 123.62 million in debt, giving a net cash position of -74.37 million.

Cash & Cash Equivalents	49.25M
Total Debt	123.62M
Net Cash	-74.37M
Net Cash Per Share	n/a
Equity (Book Value)	632.80M
Book Value Per Share	12.16
Working Capital	373.77M

Cash Flow

In the last 12 months, operating cash flow was 174.52 million and capital expenditures -63.49 million, giving a free cash flow of 111.03 million.

Operating Cash Flow	174.52M
Capital Expenditures	-63.49M
Free Cash Flow	111.03M
FCF Per Share	n/a

Margins

Gross margin is 62.40%, with operating and profit margins of 20.79% and 16.73%.

Gross Margin	62.40%
Operating Margin	20.79%
Pretax Margin	21.75%
Profit Margin	16.73%
EBITDA Margin	23.91%
EBIT Margin	20.79%
FCF Margin	15.33%

Dividends & Yields

This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 1.30%.

Dividend Per Share	0.76
Dividend Yield	1.30%
Dividend Growth (YoY)	-15.28%
Years of Dividend Growth	n/a
Payout Ratio	39.48%
Buyback Yield	n/a
Shareholder Yield	1.30%
Earnings Yield	3.98%
FCF Yield	3.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:41L has an Altman Z-Score of 8.85 and a Piotroski F-Score of 6.

Altman Z-Score	8.85
Piotroski F-Score	6